Clinical and molecular cytogenetic characterisation of a newly recognised microdeletion syndrome involving 2p15-16.1

Background: During whole genome microarray-based comparative genomic hybridisation (array CGH) screening of subjects with idiopathic intellectual disability, we identified two unrelated individuals with a similar de novo interstitial microdeletion at 2p15-2p16.1. Both individuals share a similar cli...

Full description

Saved in:
Bibliographic Details
Published inJournal of medical genetics Vol. 44; no. 4; pp. 269 - 276
Main Authors Rajcan-Separovic, E, Harvard, C, Liu, X, McGillivray, B, Hall, J G, Qiao, Y, Hurlburt, J, Hildebrand, J, Mickelson, E C R, Holden, J J A, Lewis, M E S
Format Journal Article
LanguageEnglish
Published London BMJ Publishing Group Ltd 01.04.2007
BMJ
BMJ Publishing Group LTD
BMJ Group
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Background: During whole genome microarray-based comparative genomic hybridisation (array CGH) screening of subjects with idiopathic intellectual disability, we identified two unrelated individuals with a similar de novo interstitial microdeletion at 2p15-2p16.1. Both individuals share a similar clinical phenotype including moderate to severe intellectual disability, autism/autistic features, microcephaly, structural brain anomalies including cortical dysplasia/pachygyria, renal anomalies (multicystic kidney, hydronephrosis), digital camptodactyly, visual impairment, strabismus, neuromotor deficits, communication and attention impairments, and a distinctive pattern of craniofacial features. Dysmorphic craniofacial features include progressive microcephaly, flat occiput, widened inner canthal distance, small palpebral fissures, ptosis, long and straight eyelashes, broad and high nasal root extending to a widened, prominent nasal tip with elongated, smooth philtrum, rounding of the upper vermillion border and everted lower lips. Methods: Clinical assessments, and cytogenetic, array CGH and fluorescence in situ hybridisation (FISH) analyses were performed. Results: The microdeletions discovered in each individual measured 4.5 Mb and 5.7 Mb, spanning the chromosome 2p region from 57.2 to 61.7 Mb and from 56 to 61.7 Mb, respectively. Each deleted clone in this range demonstrated a dosage reduction from two to one copy in each proband except for clone RP11-79K21, which was present in three copies in each proband and in four copies in their respective parents (two per each chromosome 2 homologue). Discussion: The common constellation of features found in the two affected subjects indicates that they have a newly recognised microdeletion syndrome involving haploinsufficiency of one or more genes deleted within at least a 4.5-Mb segment of the 2p15-16.1 region.
Bibliography:Correspondence to:
 Dr M E Suzanne Lewis
 Department of Medical Genetics, The University of British Columbia, The Child and Family Research Institute, 4500 Oak Street, Vancouver, B.C., Canada V6H 3N1; slewis@cw.bc.ca
local:0440269
href:jmedgenet-44-269.pdf
istex:16CDD5B1335C0B923F99C6499C2AF9D8D27D61B2
ark:/67375/NVC-DX0W3BJV-9
PMID:16963482
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ObjectType-Case Study-2
ObjectType-Correspondence-3
ObjectType-Article-4
ObjectType-Report-1
E Rajcan‐Separovic, C Harvard, Y Qiao, ECR Mickelson, JJA Holden and MES Lewis are members of The Autism Spectrum Disorders – Canadian American Research Consortium (ASD‐CARC; www.autismresearch.ca,www.asdcarc.com).
ISSN:0022-2593
1468-6244
1468-6244
DOI:10.1136/jmg.2006.045013